Human Tumor Necrosis Factor Ligand Superfamily Member 13 / CD256 (TNFSF13) Protein

REQUEST MORE INFO
Catalogue No: abx069548
Price: US$246.50
(Size: 10 µg)

Click on the image to see the image legend

Available Options

* Size:







Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Recombinant Tumor Necrosis Factor Ligand Superfamily, Member 13 (TNFSF13) is a recombinant Human protein produced in a Prokaryotic expression system (E. coli).

Target Tumor Necrosis Factor Ligand Superfamily Member 13 / CD256 (TNFSF13)
Origin Human
Expression Recombinant
Tested Applications WB, SDS-PAGE
Host E. coli
Conjugation Unconjugated
Form Lyophilized
Purity > 97%
Reconstitution Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/ml. Do not vortex.
Storage Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.
UniProt Primary AC O75888 (UniProt, ExPASy)
UniProt Secondary AC A8MYD5, B4DVT2, Q541E1, Q5U0G8, Q96HV6, Q9P1M8, Q9P1M9
Gene Symbol TNFSF21
GeneID 8741
OMIM 604472
HGNC 11928
KEGG hsa:8741
Ensembl ENSG00000161955
String 9606.ENSP00000343505
Molecular Weight Calculated MW: 17.6 kDa
Observed MW (SDS-PAGE): 15 kDa

Possible reasons why the actual band size differs from the predicted band size:
1. Splice variants. Alternative splicing may create different sized proteins from the same gene.
2. Relative charge. The composition of amino acids may affect the charge of the protein.
3. Post-translational modification. Phosphorylation, glycoslyation, methylation etc. may affect the band size.
4. Post-translational cleavage. Many proteins are synthesised as pro-proteins, and then cleaved to give the active form.
5. Polymerisation of the target protein. Dimerisation, multimerisation etc. will increase the band size observed.
Sequence Fragment Ala105-Leu250
Sequence AVLTQK QKKQHSVLHL VPINATSKDD SDVTEVMWQP ALRRGRGLQA QGYGVRIQDA GVYLLYSQVL FQDVTFTMGQ VVSREGQGRQ ETLFRCIRSM PSHPDRAYNS CYSAGVFHLH QGDILSVIIP RARAKLNLSP HGTFLGFVKL
Tag N-terminal His tag
Buffer Prior to lyophilization: 100 mM NaHCO3, 500 mM NaCl, pH 8.3, containing 0.01% Sarcosyl, 5% Trehalose.
Activity Not tested
Concentration Prior to lyophilization: 200 µg/ml
Availability Shipped within 5-7 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on Tumor Necrosis Factor Ligand Superfamily Member 13 / CD256 (TNFSF13)


Write a review

Tags:
(Click to show)